Axsome Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $26M | 213k | 121.45 |
| 2025-06-30 | $62M | 596k | 104.39 |
| 2025-03-31 | $34M | 289k | 116.63 |
| 2024-12-31 | $13M | 147k | 84.61 |
| 2024-09-30 | $4.3M | 48k | 89.87 |
| 2024-06-30 | $3.2M | 40k | 80.50 |
| 2024-03-31 | $4.9M | 61k | 79.80 |
| 2023-12-31 | $3.2M | 40k | 80.00 |
| 2023-09-30 | $2.3M | 33k | 69.89 |
| 2023-06-30 | $1.0M | 15k | 71.86 |
| 2023-03-31 | $1.0M | 16k | 61.68 |
| 2022-12-31 | $1.0M | 13k | 77.13 |
| 2022-09-30 | $818k | 18k | 44.68 |
| 2022-06-30 | $551k | 14k | 38.32 |
| 2022-03-31 | $678k | 16k | 41.36 |
| 2021-12-31 | $114k | 3.0k | 37.63 |
| 2021-09-30 | $308k | 9.3k | 32.98 |
| 2021-06-30 | $754k | 11k | 67.45 |
| 2021-03-31 | $535k | 9.4k | 56.67 |
| 2020-12-31 | $677k | 8.9k | 75.95 |
| 2020-09-30 | $959k | 14k | 71.28 |
| 2020-06-30 | $1.4M | 17k | 82.32 |
| 2020-03-31 | $1.2M | 21k | 58.85 |
| 2019-12-31 | $4.6M | 44k | 103.44 |
| 2019-09-30 | $926k | 46k | 20.25 |
| 2019-06-30 | $86k | 3.4k | 25.63 |
| 2019-03-31 | $26k | 1.8k | 14.17 |
| 2018-06-30 | $998 | 279 | 3.58 |
| 2017-09-30 | $1.0k | 240 | 4.17 |
| 2017-06-30 | $8.0k | 1.4k | 5.79 |
| 2017-03-31 | $1.0k | 269 | 3.72 |
| 2016-12-31 | $12k | 1.8k | 6.86 |
| 2016-06-30 | $7.0k | 937 | 7.47 |
| 2016-03-31 | $103k | 12k | 8.62 |